This site has been optimized to work with modern browsers and does not fully support your version of Internet Explorer.

£4.5 million for clinical research consortium to tackle the global threat of epidemic infections diseases


The International Severe Acute Respiratory and emerging Infections Consortium (ISARIC) has been awarded £4.5 million to accelerate clinical research to prevent illness and deaths from epidemic infectious diseases.


ISARIC – whose Global Support Centre is hosted by the University of Oxford – is a world-wide, grass-roots consortium of clinical research networks, working together on epidemic infections such as pandemic influenza, Ebola, Lassa fever, and plague.